Evelyn Partners Investment Management Services Ltd Buys 109,924 Shares of Colgate-Palmolive Company $CL

Evelyn Partners Investment Management Services Ltd lifted its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 29,391.4% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 110,298 shares of the company’s stock after purchasing an additional 109,924 shares during the period. Colgate-Palmolive accounts for 0.9% of Evelyn Partners Investment Management Services Ltd’s holdings, making the stock its 26th biggest position. Evelyn Partners Investment Management Services Ltd’s holdings in Colgate-Palmolive were worth $9,207,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in the company. Brighton Jones LLC raised its holdings in shares of Colgate-Palmolive by 4.4% in the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock valued at $962,000 after purchasing an additional 450 shares during the period. Bank Julius Baer & Co. Ltd Zurich lifted its position in shares of Colgate-Palmolive by 8.4% in the first quarter. Bank Julius Baer & Co. Ltd Zurich now owns 7,176 shares of the company’s stock valued at $672,000 after buying an additional 556 shares during the last quarter. Carnegie Investment Counsel boosted its stake in shares of Colgate-Palmolive by 73.8% during the 1st quarter. Carnegie Investment Counsel now owns 33,306 shares of the company’s stock worth $3,038,000 after acquiring an additional 14,144 shares during the period. Lifeworks Advisors LLC raised its stake in Colgate-Palmolive by 10.4% in the 1st quarter. Lifeworks Advisors LLC now owns 8,350 shares of the company’s stock valued at $782,000 after acquiring an additional 784 shares during the period. Finally, Cetera Investment Advisers boosted its position in Colgate-Palmolive by 15.0% during the first quarter. Cetera Investment Advisers now owns 156,262 shares of the company’s stock worth $14,642,000 after purchasing an additional 20,339 shares during the period. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on CL shares. JPMorgan Chase & Co. lowered their price target on shares of Colgate-Palmolive from $88.00 to $87.00 and set an “overweight” rating on the stock in a report on Monday, November 3rd. Citigroup reduced their price target on Colgate-Palmolive from $105.00 to $95.00 and set a “buy” rating for the company in a research note on Monday, November 3rd. Wells Fargo & Company dropped their target price on Colgate-Palmolive from $80.00 to $77.00 and set an “underweight” rating for the company in a report on Monday, November 3rd. Deutsche Bank Aktiengesellschaft set a $86.00 price target on shares of Colgate-Palmolive in a research note on Friday, October 10th. Finally, Bank of America decreased their target price on shares of Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. Nine investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $89.87.

Colgate-Palmolive Price Performance

CL stock opened at $80.97 on Friday. The company’s 50-day moving average price is $78.73 and its two-hundred day moving average price is $84.84. The firm has a market cap of $65.27 billion, a P/E ratio of 22.74, a P/E/G ratio of 4.44 and a beta of 0.35. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 6.79. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $100.18.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, October 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.02. The business had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.17 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The firm’s revenue for the quarter was up 1.9% on a year-over-year basis. During the same quarter last year, the business posted $0.91 EPS. On average, analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, November 14th. Stockholders of record on Friday, October 17th were issued a dividend of $0.52 per share. The ex-dividend date of this dividend was Friday, October 17th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.6%. Colgate-Palmolive’s payout ratio is 58.26%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.